Find Academic Supervisors

Edward H. Kaplan is the William N. and Marie A. Beach Professor of Management Sciences at the Yale School of Management, Professor of Public Health at the Yale School of Medicine, and Professor of Engineering at the Yale School of Engineering and Applied Sciences. He holds secondary appointments in Chemical and Environmental Engineering, Health Policy & Management, the Institution for Social and Policy Studies, and Statistics. Education: PhD in Urban Studies, Massachusetts Institute of Technology (1984) SM in Mathematics, Massachusetts Institute of Technology (1982) SM in Operations Research and City Planning, Massachusetts Institute of Technology (1979) BA in Urban/Economic Geography, McGill University (1977) Kaplan is an expert in operations research, mathematical modeling, and statistics, focusing on public policy and management. His research spans counterterrorism, HIV prevention, bioterrorism, and public health modeling. He has developed models for suicide bomber detection, smallpox response logistics, needle exchange program effectiveness, and wastewater-based disease surveillance. His work has been recognized with numerous awards, including the Koopman Prize (2003, 2005), INFORMS President’s Award (2002), Charles C. Shepard Science Award (2009), and INFORMS Fellow (2005). He has also served as President of INFORMS (2016) and co-directs the Daniel Rose Technion-Yale Initiative in Homeland Security.

• Operations Research
• Mathematical Modeling
• Statistics
• +6 more

Carol R Kuntz serves as an Adjunct Professor in the Science, Technology and International Affairs (STIA) program at Georgetown University, teaching courses on artificial intelligence policy implications. She concurrently holds an adjunct fellowship at the Center for Strategic and International Studies (CSIS) in the Strategic Technologies Program. With over 30 years of U.S. Department of Defense experience, she specializes in adapting national security frameworks to technological disruptions. Her academic credentials include: Ph.D. in Political Science from the Massachusetts Institute of Technology MPA from Princeton University B.A. with Honors from Cornell University Dr. Kuntz's research bridges defense strategy and emerging technologies, focusing on AI governance in military contexts and biotechnological threats. Her work analyzes autonomous weapons ethics, genome editing risks, and WMD defense systems through interdisciplinary lenses spanning computer science, political theory, and public health policy. Recent publications examine AI integration in warfare and genome manipulation governance, revealing consistent themes of proactive policy design for technological existential risks. These studies highlight her strategic approach to anticipating security vulnerabilities before crises emerge. Her accolades include: Secretary of Defense Medal for Meritorious Civilian Service (awarded twice) Dr. Kuntz's government leadership encompassed directing Project Bioshield and the Domestic Nuclear Detection Office, demonstrating extensive grant management and interagency coordination expertise. Her academic mentorship leverages decades of high-stakes policy implementation experience. At CSIS, she contributes to strategic technology assessments while maintaining active academic roles. Her career trajectory—from Cold War defense planning to AI policy—exemplifies continuous adaptation to evolving security paradigms through institutional collaboration.

• Artificial Intelligence Policy
• Biodefense
• National Security Policy
• +3 more

Crystal R. Watson is an Associate Professor in the Department of Environmental Health and Engineering at Johns Hopkins University, with a joint role as Senior Associate at the Johns Hopkins Center for Health Security. She specializes in public health preparedness, risk assessment during emergencies, and biodefense policy. She holds a DrPH and MPH from the Johns Hopkins Bloomberg School of Public Health and a BA from the University of Colorado. Her research focuses on federal funding and management of biodefense programs, crisis decision-making, and global health security. Notable projects include assessments of Taiwan’s IHR compliance and analysis of Hurricane Katrina’s medical response. She serves as Associate Editor of Health Security and has authored over 30 peer-reviewed articles. Key contributions include publications on biological threat characterization, pandemic event management, and Ebola risk perception. She advises on policies to address catastrophic biological risks and has led projects funded by federal agencies.

• Public Health Preparedness
• Biodefense
• Risk Assessment
• +3 more

Jennifer Golden is an Associate Professor in the Department of Pharmaceutical Sciences at the School of Pharmacy , University of Wisconsin-Madison . Her research focuses on synthetic medicinal chemistry to develop novel antiviral and anti-parasitic agents for diseases like alphavirus infections and kinetoplastid parasites. The Golden Lab emphasizes chemical methodology development and structure-activity relationship analysis through collaborations assessing compound efficacy in cell and animal models . Research Projects Quinazolinone Rearrangement: Developing synthetic transformations for amidine formation and ring-fused scaffolds. Anti-Alphaviral Agents: Creating FDA-approved therapeutic candidates for mosquito-borne RNA viruses. Broad-Spectrum Antiparasitics: Optimizing compounds for malaria, African sleeping sickness, and leishmaniasis. Publications highlight her work on ML336 (anti-VEEV), quinazolinone derivatives , and collaborations with experts in high-throughput screening and structural biology . Her lab trains students in hit-to-lead optimization , regioselective synthesis , and medicinal chemistry tactics . Education: B.S. (1996) – Eastern Illinois University Ph.D. (2002) – University of Kansas Postdoctoral Research (2004) – Stanford University

• Synthetic Medicinal Chemistry
• Antiviral Drug Development
• Antiparasitic Drug Discovery
• +3 more

Shoshana R. Shelton is a Professor at the RAND School of Public Policy and a Policy Researcher at the RAND Corporation. Her work centers on program evaluation, public health systems, emergency preparedness, and national health security, with significant contributions to pandemic response, violence prevention, and crisis decision-making. She has led major projects for federal agencies including the CDC, DHS, FEMA, and the U.S. Secret Service. Education: M.P.H., The Ohio State University B.A. in English, Denison University Her research focuses on strengthening public health infrastructure through performance measurement, logic modeling, and stakeholder engagement. She has developed tools such as tabletop exercises for continuity of operations in public health laboratories and led after-action reviews of the public health response to COVID-19. Her work emphasizes building resilience against biological threats, natural disasters, and targeted violence. Shelton's recent publications highlight trends in emergency alert systems, disaster resilience, criminal justice reform during pandemics, and equitable health security research investment. She advocates for evidence-based policies that balance bioterrorism preparedness with responses to natural disasters and climate-related emergencies. Scientific Awards: No awards listed in the provided text. She has advised or collaborated with numerous federal and state agencies, contributing to national health security through rigorous evaluation and policy analysis. Her grants and projects reflect sustained funding from DHS, CDC, and other federal bodies focused on improving public safety and health system readiness. She has also led initiatives on behavioral threat assessment in schools and wearable technology for law enforcement wellness. Labs and Teams: Previously led a four-year project on mass attacks and targeted violence for the U.S. Secret Service. Collaborated with the Association of Public Health Laboratories (APHL) on continuity of operations planning. Contributed to the Priority Criminal Justice Needs Initiative, fostering innovation across law enforcement, courts, and corrections.

• Program Evaluation
• Performance Measurement
• Public Health
• +12 more

Lawrence M. Wein is the Jeffrey S. Skoll Professor of Management Science at Stanford University's Graduate School of Business, where he also serves as Senior Associate Dean of Academic Affairs. He holds a PhD in Operations Research from Stanford (1988) and has taught operations management at MIT (1988–2002) and Stanford since 2003. His research spans operations management, public health, and homeland security, with notable contributions to HIV therapy optimization, bioterror response logistics, and forensic science innovations. His academic roles include Senior Fellow at Stanford’s Center for International Security and Cooperation, and editorial leadership as Editor-in-Chief of Operations Research (2000–2005). Notable awards include the Kimball Medal, Lanchester Prize, and membership in the National Academy of Engineering. Research interests emphasize applying operations research to real-world challenges, such as optimizing radiation detection systems, analyzing sexual assault kit backlogs, and improving ballistic imaging techniques. His work bridges theoretical models with practical policy, impacting areas like healthcare, counterterrorism, and criminal justice. Key contributions include developing the workload regulating release policy in semiconductor manufacturing, influencing U.S. smallpox vaccination strategy, and advancing mathematical models for cancer treatment and pandemic influenza control. His recent focus includes forensic genetic genealogy and crime-solving technologies. Grants and collaborations span industries, governments, and academic institutions, reflecting interdisciplinary impact. His teaching includes courses on operations management, stochastic networks, and homeland security applications.

• Operations Management
• Public Health
• Homeland Security
• +5 more

Peter R. Neumann is a Professor of Security Studies at King's College London , where he founded and directed the International Centre for the Study of Radicalisation (ICSR). He also serves as a Research Fellow at the Changing Character of War Programme (University of Oxford) and a Senior Researcher for the European Commission’s Radicalisation Awareness Network (RAN-PS). Previously, he held visiting or adjunct roles at Sciences Po (Lyon), Georgetown University, Johns Hopkins University, and the University of St. Gallen. Education: PhD in War Studies (King's College London), MA in Political Science (Free University of Berlin). His research focuses on radicalisation , extremism , terrorism , and counter-terrorism , with a particular emphasis on online extremism , migration and security , and foreign fighter networks . His publications include Radicalized: New Jihadists and the Threat to the West (2016), Bluster: Donald Trump’s War on Terror (2020), and The New World Disorder (2023), an intellectual history of Western foreign policy post-Cold War. Professor Neumann’s academic output spans 15+ years , covering topics such as prison radicalization (2020), hybrid terrorism (2020), bioterrorism during the pandemic (2020), and systemic lessons from European terrorist plots (2019–2020). His work often bridges empirical analysis (e.g., socio-economic drivers of Islamic State recruitment, 2021) and policy-oriented contributions (e.g., CVE strategies in Europe, 2019). He has advised Western governments and international institutions extensively, including a role as OSCE Special Representative on Countering Violent Extremism in 2017. Prior to academia, he worked as a radio journalist in Germany.

• Radicalisation
• Extremism
• Terrorism
• +6 more

Sonia Ben Ouagrham-Gormley is an Associate Professor at the Schar School of Policy and Government, George Mason University. She is affiliated with the Biodefense Program, the Center for Global Studies, and the Department of History and Art History’s Master of Arts in Interdisciplinary Studies (MAIS) program. Her work bridges policy, security, and science, with a regional focus on the former Soviet Union. Her research centers on the proliferation of weapons of mass destruction, including nuclear, chemical, and biological weapons. She investigates how tacit knowledge affects weapons development, the effectiveness of export controls, and the challenges of dissuading bioweapons programs. Her work also covers WMD-related trafficking, sanctions, and the redirection of former weapons scientists. She employs qualitative methods and interdisciplinary frameworks from science and technology studies. She has secured research funding from the U.S. Departments of Defense, State, and Energy, as well as from the Nuclear Threat Initiative and the Carnegie Corporation of New York. Her work contributes to programs such as the Department of Defense’s Cooperative Threat Reduction Program, aimed at reducing global WMD risks. Ben Ouagrham-Gormley has held significant research roles, including Senior Research Associate at the James Martin Center for Nonproliferation Studies (CNS), where she directed research at the CNS Almaty office in Kazakhstan. She was also the founding Editor-in-Chief of the International Export Control Observer and served as an Adjunct Professor at Johns Hopkins University School of Advanced International Studies. Her educational background includes a PhD in Development Economics from EHESS in Paris, a graduate degree in Strategy and Defense Policy from the Institute of Higher International Studies in Paris, a Master’s in Applied Foreign Languages (economics, law, Russian, and English) from the University of Paris X-Nanterre, and dual undergraduate degrees in Applied Foreign Languages and English Literature from the same institution. She is fluent in French, English, Russian, and spoken Arabic, with beginner-level Kazakh. Her multilingual abilities support her field research and international collaborations, particularly in post-Soviet states.

• Weapons of Mass Destruction (WMD) Proliferation
• Nonproliferation and Arms Control
• Biodefense
• +16 more

Paul Keim is a Distinguished Professor at Northern Arizona University and holds the Cowden Endowed Chair in Microbiology. He serves as a Regents Professor of Biology and leads the Pathogen Genomics Program, a joint initiative between TGen and Northern Arizona University. His work focuses on bacterial pathogen genomics, biodefense, and molecular epidemiology. Institution: Northern Arizona University & TGen Division: Immunology and Microbial Genomics Division Email: pkeim@tgen.org Dr. Keim specializes in genomic forensic analysis of biothreat agents like Bacillus anthracis (anthrax), Yersinia pestis (plague), and Francisella tularensis (tularemia). His research includes understanding pathogen evolution, ecology, and epidemiology to develop advanced diagnostics and therapeutics. He has collaborated with federal agencies on bioterrorism response, notably providing critical forensic analysis during the 2001 anthrax attacks. Key publication trends include genomic surveillance of bacterial pathogens, evolutionary dynamics , and molecular identification tools . His studies often employ whole-genome sequencing , SNP analysis , and MLVA techniques. Scientific Awards Cowden Endowed Chair in Microbiology, Northern Arizona University Dr. Keim's work has shaped modern bioforensic methodologies , particularly for anthrax and plague. His lab's 1993 analysis of the Tokyo anthrax attack linked it to Aum Shinrikyo, establishing genomic tools as critical for biocrime investigations.

• Pathogen Genomics
• Molecular Epidemiology
• Bacterial Pathogens
• +6 more

Dr. Curt Harris is an Associate Professor and Director of the Institute for Disaster Management (IDM) at the University of Georgia's College of Public Health. He holds concurrent appointments in Health Policy & Management and Epidemiology & Biostatistics. His roles include overseeing undergraduate and graduate educational programs, directing IDM's research and outreach initiatives, and serving as a liaison between the college administration and external partners. Dr. Harris earned a BS in Chemistry from Georgia College and State University and a PhD in Toxicology from UGA. His career at UGA spans over a decade, encompassing staff and faculty roles before becoming IDM Director. His research focuses on disaster management, public health preparedness, and emergency response systems, with recent emphasis on healthcare workforce resilience, nuclear event response, and pandemic preparedness. His recent publications highlight interdisciplinary approaches to disaster challenges, including nuclear fallout modeling, CNA staffing shortages, and integrating machine learning in burn patient outcomes. Dr. Harris leads major projects like the South Carolina Low Country Emergency Preparedness Program and the Southern Regional Disaster Response System. His work has been featured in media outlets like NPR, CBS46, and the Huffington Post. Dr. Harris teaches courses such as Introduction to Disaster Management and Public Health Crises and Disaster Management . He advocates for disaster education as a core competency in public health curricula. His professional service includes coordinating the CPH graduate program and advising on emergency medical protocols.

• Disaster Management
• Public Health Preparedness
• Emergency Response
• +5 more

Shelley A. Hearne is the Deans Sommer and Klag Distinguished Professor of the Practice in Public Health and a faculty member in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. She also serves as director of the Lerner Center for Public Health Advocacy and executive director of the Forsythia Foundation. Her work centers on strengthening public health advocacy, policy engagement, and health equity in urban and governmental settings. DrPH, Columbia Mailman School of Public Health, 1994 MPH, Columbia Mailman School of Public Health, 1988 AB, Bowdoin College, 1983 Dr. Hearne’s research focuses on public health advocacy, health policy, urban health systems, food safety, bioterrorism preparedness, and pandemic response. She explores how to build advocacy capacity within the public health workforce and develop equitable, evidence-based policies. Her work emphasizes the integration of science, policy, and community engagement to improve health outcomes. Her recent publications demonstrate a consistent focus on policy development, advocacy training, and equity-centered approaches to public health. Articles analyze syllabi in public health education, advocate for competency-based training, and promote tools for equitable policy-making. Her research spans journals like Journal of Public Health Management and Practice and book chapters with Oxford University Press and APHA Press. American Public Health Association Executive Director’s Citation Bowdoin College Common Good Award Senator Frank Lautenberg Award for lifetime achievement in public health advocacy (2006) Delta Omega Curricula Award (2004) Elected member, Delta Omega Society, Alpha Eta Chapter (2006) Dr. Hearne has led major public health initiatives including founding CityHealth and serving as executive director of the Big Cities Health Coalition and managing director at The Pew Health Group. She has authored influential national reports, testified before Congress, and contributed to accreditation and oversight of public health schools. She currently teaches courses in public health advocacy and health policy leadership. She is also a trustee at Bowdoin College and chairs their Committee on Inclusion. Dr. Hearne leads the Lerner Center for Public Health Advocacy, a hub for research, training, and policy engagement aimed at building advocacy capacity across the public health field. Her work fosters collaboration between academia, government, and nonprofit sectors to advance health equity and effective public health practice.

• Public Health Advocacy
• Health Policy
• Urban Health
• +9 more

Eileen M. Barry serves as Professor in the Department of Medicine at the University of Maryland School of Medicine, with secondary appointments in Medical and Research Technology and Microbiology and Immunology. She directs education for the Center of Vaccine Development & Global Health, leading research on vaccines against enteric pathogens and biodefense threats. Her academic background includes: B.A. in Biology from University of Delaware (1985) Ph.D. in Microbiology and Immunology from Virginia Commonwealth University Medical College of Virginia (1991) Postdoctoral Fellowship at University of Maryland School of Medicine Center for Vaccine Development (1992-1994) Postdoctoral Fellowship at University of Maryland School of Medicine Center for Vaccine Development (1994-1996) Dr. Barry's research focuses on oral live attenuated vaccines targeting Shigella , enterotoxigenic E. coli (ETEC), and Francisella tularensis . Her work spans pathogen engineering, host-pathogen interactions, and clinical translation, with emphasis on pediatric and military applications. Key methodologies include human enteroid models, BSL3/ABSL3 pathogenesis studies, and immunogenicity assessment. Recent publications reveal a strategic shift toward multivalent platforms and advanced organoid systems for predicting human immune responses. Her scientific recognition includes: University System of Maryland PROMISE Alliance Outstanding Faculty Mentor (2015) Faculty Teacher of the Year Award (2011) Teaching Commendation in Host Defenses (2009/2012) As a dedicated mentor, Dr. Barry has served on Graduate Student Admissions Committees since 2007 and received special recognition for advancing underrepresented STEM students. Her substantial NIH funding portfolio includes: P01AI125181: Pathogenesis of E. Coli and Shigella in Human Enteroid Models (2016-2021) R01AI125841: Serological Assays for Shigella Vaccine Efficacy (2016-2021) R01AI123129: Tularemia Vaccine Protection Correlates (2016-2021) Her laboratory operates BSL2/3 and ABSL2/3 facilities, integrating genetic engineering, organoid models, and genomics to dissect enteric pathogenesis and accelerate vaccine development for global health impact.

• Vaccine Development
• Enteric Pathogens
• Shigella
• +5 more

Dr. Steven Aronin is an Associate Clinical Professor of Medicine at Yale School of Medicine and serves as Chief of Infectious Disease at Waterbury Hospital. He holds multiple leadership roles including Medical Director of the Waterbury Hospital Infectious Disease and Travel Clinic, Program Director for Ryan White HIV Programs, and Hospital Epidemiologist. His academic work focuses on infectious diseases, particularly meningitis, endocarditis, HIV/AIDS, and antibiotic efficacy. Dr. Aronin completed his MD at Ross University School of Medicine and residency at Yale Primary Care Internal Medicine Program. He has been a Core Faculty member at Waterbury Hospital since 2009 and oversees the Yale-Waterbury Internal Medicine Residency Program's Infectious Disease training. He is also President of the Connecticut Infectious Disease Society. His research emphasizes translational antibiotic studies, particularly sulopenem's efficacy against resistant pathogens like E. coli and K. pneumoniae. Recent work includes phase 3 trials comparing sulopenem to ertapenem for intra-abdominal infections, and evaluating its use in UTIs and anthrax models. Key findings include sulopenem's superior efficacy in UTIs and its potential as a biodefense agent against inhalational anthrax. Dr. Aronin actively contributes to clinical guidelines through studies on HIV screening integration and bacteriuria's clinical impact. His work bridges academic research with direct patient care, emphasizing antibiotic stewardship and improving infectious disease treatment outcomes.

• Infectious Diseases
• HIV/AIDS Research
• Antimicrobial Resistance
• +5 more

Henry H. Willis is Associate Director of the Meselson Center, Senior Policy Researcher at RAND, and Professor of Policy Analysis at the RAND School of Public Policy. His work focuses on reducing risks from biological threats, critical infrastructure, climate change, and terrorism through rigorous policy analysis and risk management frameworks. Ph.D. in Engineering and Public Policy, Carnegie Mellon University M.S. in Environmental Engineering, University of Cincinnati B.A. in Chemistry, University of Pennsylvania Willis is a leading expert in risk analysis, with research spanning biosecurity, homeland security, energy security, environmental management, and public health preparedness. His work integrates engineering, policy, and systems thinking to evaluate national preparedness for chemical, biological, nuclear, and radiological threats, as well as climate and disaster risks. He has developed analytical frameworks for biosurveillance, infrastructure resilience, and terrorism risk modeling. His recent publications focus on catastrophic cyber risk insurance, wastewater surveillance sustainability, food-energy-water security, soft target protection, and risk-based decisionmaking in public health and homeland security. These works reflect a consistent theme of applying quantitative risk analysis to inform national and international policy. Member, Council on Foreign Relations Committee Member, Science and Governance Committees of the Society for Risk Analysis Willis has testified before Congress, advised U.S. and international government agencies, and served on National Academy of Sciences committees. His prior experience includes program evaluation at the White House Office of Management and Budget and infrastructure design as a water and wastewater engineer. He leads research initiatives on strategic planning at DHS, border security, and energy resilience, often advising on grant programs and regulatory impact analysis. He is affiliated with the Meselson Center and has directed programs within the RAND Homeland Security Research Division, including the Strategy, Policy, and Operations Program and the Infrastructure, Immigration, and Security Operations Program. His work supports public safety decisionmaking through tools like the Pardee RAND Food-Energy-Water Index and risk maturity assessments.

• Risk Analysis and Management
• Homeland Security
• Critical Infrastructure Protection
• +13 more

David S. Markenson is a Professor at New York Medical College's School of Health Sciences and Practice , where he co-founded the Center for Disaster Medicine (CDM) in 2005 and currently serves as its Director . He is also the Senior Associate Dean for Research and Medical Director of the Center of Excellence in Precision Responses to Bioterrorism and Disasters. His career spans academic leadership, clinical practice, and healthcare administration across institutions like Sky Ridge Medical Center and Hospital Corporation of America. Education: MD from Albert Einstein College of Medicine, MBA from University of Massachusetts Amherst, Pediatrics residency at NYU, Fellowship in Pediatric Emergency Medicine at Montefiore Medical Center As a board-certified expert in Pediatrics , Pediatric Critical Care , and Clinical Informatics , Dr. Markenson's research focuses on disaster medicine , pediatric emergency care , and healthcare system preparedness . His work includes developing international first aid guidelines and improving disability-inclusive disaster planning . Recent publications highlight his contributions to first aid science , heat stroke management , and pediatric cardiac care . He has authored over 250 presentations and key texts in disaster medicine. Scientific accolades include Fellowships in the American College of Emergency Physicians and multiple national academies. Grants: Principal investigator on federal, state, and regional grants for disaster preparedness Leadership: Former Chair of American Red Cross Scientific Advisory Council, Chair of International Federation's Evidence-Based Health Group

• Disaster Medicine
• Public Health Preparedness
• Pediatric Emergency Medicine
• +3 more